Importance Per the World Health Organization 2016 integrative classification, newly
diagnosed glioblastomas are separated into isocitrate dehydrogenase gene 1 or 2 (IDH)–wild-type …

Brain tumors are a diverse group of neoplasms that often carry a poor prognosis for patients.
Despite tremendous efforts to develop diagnostic tools and therapeutic avenues, the …

The blood‐brain barrier (BBB) remains a formidable obstacle in medicine, preventing efficient
penetration of chemotherapeutic and diagnostic agents to malignant gliomas. Here, a …

Background Terminology to describe extent of resection in glioblastoma is inconsistent
across clinical trials. A surgical classification system was previously proposed based upon …

PURPOSE In patients with diffuse low-grade glioma (LGG), the extent of surgical tumor resection
(EOR) has a controversial role, in part because a randomized clinical trial with different …

Nuclear factor-κB (NF-κB) is a ubiquitous transcription factor that regulates multiple aspects
of cancer formation, growth, and treatment response. Glioblastoma (GBM), the most common …

Magnetic particles that can be precisely controlled under a magnetic field and transduce
energy from the applied field open the way for innovative cancer treatment. Although these …

As therapies continue to increase the lifespan of patients with breast cancer, the incidence
of brain metastases has steadily increased, affecting a significant number of patients with …

Introduction Multiple studies have demonstrated that improved extent of resection is associated
with longer overall survival for patients with both high and low grade glioma. Awake …

OBJECTIVE Tuberculum sellae meningiomas (TSMs) are surgically challenging tumors that
can severely impair vision. Debate exists regarding whether the transcranial (TC) or …